New Stroke Drug, Pig Liver Xenotransplant, and Cardiac Risks in Immunotherapy

Today we cover a factor eleven-a inhibitor that cuts stroke recurrence without added bleeding risk, the first orthotopic pig liver transplant in a human, and new cardiac safety data on checkpoint inhibitors. We also review where systemic therapy for liver cancer stands, and a Cell study identifying the protein that executes copper-triggered cell death. Plus a quick rundown of five more studies spanning oncology, nephrology, cardiology, and neurology.